https://www.selleckchem.com/pr....oducts/Temsirolimus.
3% (CI, 2.3% to 4.3%), with a lower HR of mortality in the surgery group (HR, 0.53 [CI, 0.41 to 0.69]). Observed relative effects were similar across sex; however, the observed association in absolute terms was greater in men. Surgery also was associated with lower cardiovascular mortality (HR, 0.53 [CI, 0.34 to 0.84]) and lower cancer mortality (HR, 0.54 [CI, 0.36 to 0.80]). The observational design limits causal inference. Bariatric surgery was associated with substantially lower all-cause, cardiovascular, and cancer mortality. T
Like
Comment
Share
